PER-020-04已完成未知
RANDOMIZED, DOUBLE-BLIND STUDY, CONTROLLED WITH ACTIVE COMPARATOR, OF PARALLEL GROUPS, CARRIED OUT UNDER INTERNAL BLIND CONDITIONS TO EXAMINE THE SAFETY, TOLERABILITY AND EFFECTIVENESS OF 2 DOSE OF APPRENTICATOR IN THE PREVENTION OF NAUSEA AND POST-OPERATIVE VOMITING
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2004年5月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a. The patient is at least 18 years of age.
- •b. The patient is able to understand the study procedures and agrees to participate in it by providing written informed consent.
- •c. The patient is scheduled to undergo open abdominal surgery that requires staying in the hospital until the next day (staying 24 hours in the hospital after the end of surgery).
- •d. The patient is scheduled to receive general anesthesia.
排除标准
- •a. The patient is scheduled to receive propofol for maintenance of anesthesia
- •b. Placement of a nasogastric or oral gastric tube intra or postoperatively.
- •c. The patient is allergic to pre-operative tranquillizers, operative anesthetics, postoperative analgesia, aprepitant, ondansetron or any other programmed 5-HT3 antagonist.
- •d. It is anticipated that the patient will receive neuraxial anesthesia, such as epidural, spinal or caudal anesthesia.
研究者
相似试验
已完成
不适用
A DOUBLE-BLIND, RANDOMIZED STUDY CONTROLLED WITH ACTIVE COMPARATOR MK-0767 AND METFFORMINA IN PATIENTS THAT SUFFER FROM DIABETES TYPE 2 INAPPROPRIATE CONTROL OF DIET AND EXERCISES.-E119 Non-insulin-dependent diabetes mellitus, without complicationsNon-insulin-dependent diabetes mellitus, without complicationsE119PER-065-03MERCK & CO.INC.,
已完成
不适用
RANDOMIZED, DOUBLE-BLIND STUDY, CONTROLLED BY ACTIVE COMPARATOR IN PARALLEL GROUPS TO EVALUATE THE SAFETY OF ETORICOXIB IN PATIENTS WITH OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS.-M06M06PER-067-02MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
A DOUBLE BLIND STUDY, RANDOMIZED, CONTROLLED WITH ACTIVE CONTROLLER, MULTICENTER, PARALLEL GROUP, TEST OF CONCEPT OF L-454560 IN PATIENT WITH COPD.PER-021-03MERCK SHARP & DOHME PERU S.R.L.,
进行中（未招募）
不适用
A STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S)COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITHETANERCEPT PLUS DMARD(S)Rheumatoid ArthritisEUCTR2011-005448-87-HUPfizer Inc, 235 East 42nd Street, New York, NY 10017320
进行中（未招募）
不适用
A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S)COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITHETANERCEPT PLUS DMARD(S)MedDRA version: 16.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2011-005448-87-CZPfizer Inc, 235 East 42nd Street, New York, NY 10017320